- Home
- Companies
- Regeneus Ltd.
- Products
Regeneus Ltd. products
Cell-free Topical Serum
A topical secretome-only product to reduce pain and inflammation while accelerating tissue repair. Sygenus is a cell-free topical serum and gel treatment for pain and inflammation derived from Adipose MSCs. Sygenus is composed of selective bioactive molecules from the secretome. It does not include the MSCs themselves. Sygenus reduces pain and inflammation, while accelerating tissue healing and repair. Its safety and tolerability have been confirmed in human pilot studies.
Regeneus - Selective Bioactive Molecules from the Secretome
A topical secretome-only product to reduce pain and inflammation while accelerating tissue repair. Sygenus is a cell-free topical serum and gel treatment for pain and inflammation derived from Adipose MSCs. Sygenus is composed of selective bioactive molecules from the secretome. It does not include the MSCs themselves. Sygenus reduces pain and inflammation, while accelerating tissue healing and repair. Its safety and tolerability have been confirmed in human pilot studies.
Regeneus - Adipose Allogenic MSCs
Regeneus utilises Mesenchymal Signalling Cells also known as Stromal cells or Stem cells (MSCs) derived from Fat tissue (adipose) to target and repair tissue, and reduce pain and inflammation. To repair tissue and decrease inflammation, MSCs communicate via receptors and signalling molecules produced by the cells themselves to resident tissue, restoring the balance and calming the inflammatory state.
Technologies
Regeneus Sygenus - Cell-Free Topical Serum
A topical Secretome product. Sygenus contains the bioactive molecules from the Secretome to reduce pain and inflammation while accelerating tissue healing and repair. The safety and tolerability of Sygenus have been confirmed in human pilot studies.
Regeneus Progenza - Cryopreserved Multi-Synergistic Therapy Targeting Pain and Inflammation
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor (allogeneic).
